Search Results - Laura Ballotta
- Showing 1 - 2 results of 2
-
1
Serological and cellular response to mRNA-SARS-CoV2 vaccine in patients with hematological lymphoid malignancies: Results of the study “Cervax” by Sara Mohamed, Elisa Lucchini, Francesca Sirianni, Marika Porrazzo, Laura Ballotta, Laura Ballotta, Mario Ballerini, Giovanni Maria De Sabbata, Eleonora De Bellis, Ilaria Cappuccio, Marilena Granzotto, Barbara Toffoletto, Ilaria Fortunati, Anna Russignan, Emilia Elzbieta Florea, Lucio Torelli, Francesco Zaja, Francesco Zaja
Published in Frontiers in Oncology (2023-02-01)Get full text
Article -
2
Venetoclax-based regimens in octogenarian patients with CLL: efficacy, safety, and comparison to BTKi in a multicenter cohort by Andrea Serafin, Alessandro Cellini, Enrica Antonia Martino, Federica Mazzetto, Francesco Angotzi, Anna Maria Frustaci, Monia Marchetti, Riccardo Moia, Alessandro Sanna, Costantino Riemma, Francesca Cibien, Alessandro Noto, Enrico Lista, Myriam Foglietta, Candida Vitale, Vanessa Innao, Martina Bullo, Ester Lovato, Isacco Ferrarini, Costanza Andriola, Laura Ballotta, Idanna Innocenti, Alberto Fresa, Gianmarco Favrin, Marzia Varettoni, Elisa Santambrogio, Lorella Orsucci, Raffaella Pasquale, Massimo Moratti, Luca Laurenti, Marta Coscia, Paolo Sportoletti, Roberto Marasca, Francesca Romana Mauro, Caterina Patti, Enrico Derenzini, Lydia Scarfò, Paolo Ghia, Antonio Cuneo, Alessandra Tedeschi, Livio Trentin, Massimo Gentile, Andrea Visentin
Published in Blood Advances (2025-07-01)Get full text
Article
